Burris, H. A., Bakewell, S., Bendell, J. C., Infante, J., Jones, S. F., Spigel, D. R., . . . Von Hoff, D. (2017). Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: A first-in-human, open-label, dose-escalation phase I study with expansion cohort. ESMO Open.
Chicago Style CitationBurris, Howard A., et al. "Safety and Activity of IT-139, a Ruthenium-based Compound, in Patients With Advanced Solid Tumours: A First-in-human, Open-label, Dose-escalation Phase I Study With Expansion Cohort." ESMO Open 2017.
Cita MLABurris, Howard A., et al. "Safety and Activity of IT-139, a Ruthenium-based Compound, in Patients With Advanced Solid Tumours: A First-in-human, Open-label, Dose-escalation Phase I Study With Expansion Cohort." ESMO Open 2017.